Daejeon, South Korea

Jae-Hyuk Jang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2014-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventions by Jae-Hyuk Jang: Advancing Biomedical Science

Introduction:

Jae-Hyuk Jang, based in Daejeon, KR, is a renowned inventor and researcher known for his contributions in the field of biomedical science. With four patents to his name, Jang has made significant strides in developing innovative solutions for various inflammatory diseases and cancer treatments. Working at the esteemed Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jang collaborates with notable colleagues such as Bo Yeon Kim and Jong Seog Ahn in his pursuit of groundbreaking advancements.

1. Anti-inflammatory composition comprising acylhydrazone derivative:

Jang's groundbreaking patent is centered around an anti-inflammatory composition that effectively prevents, alleviates, or treats inflammatory diseases. The active ingredient in this composition is an acylhydrazone derivative compound, its stereoisomers, or pharmaceutically acceptable salts. This novel compound inhibits inflammatory cytokines and signaling pathways, offering promising relief for conditions like dermatitis. With the potential to revolutionize inflammatory disease management, this patent represents a significant contribution to the field.

2. Tubulin polymerization inhibitor and method for synthesizing same:

In another notable patent, Jang introduces a novel tubulin polymerization inhibitor called (E)-ethyl 2-(2-methyl-3-((2-(naphtho[2,1-b]furan-2-carbonyl)hydrazono)methyl)-1H-indol-1-yl)acetate. This inhibitor demonstrates the ability to hinder mitosis and induce apoptosis, making it a potential anticancer agent. By binding to tubulin and inhibiting microtubule polymerization, Jang's compound shows promise in the field of cancer research. Moreover, the synthesis method developed by Jang simplifies the reaction and boasts an efficiency rate of 60% or higher, ensuring a high yield of the compound.

3. Collaboration with Kim and Ahn:

Jang's work is bolstered by collaboration with two remarkable colleagues, Bo Yeon Kim and Jong Seog Ahn. Together, they contribute to significant advancements in biomedical research, pooling their expertise and knowledge to push the boundaries of innovation. The combined efforts of Jang, Kim, and Ahn hold the potential to revolutionize medical treatments and contribute greatly to the scientific community.

Conclusion:

Jae-Hyuk Jang, a prominent invento

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…